top of page
Supported projects
Inatherys
Clinical-stage biotech company developing an ADC targeting the transferrin receptor and coupled with MMAE, with a first clinical trial in hematological cancers.
PSCC's entrance
Décembre 2025
Localization
FR - Île-de-France
Modality
Targeted therapy
Development status
Biotech - Phase 1b
Lauréat (s)
bottom of page